- Sai Life Sciences rose 11.87% to ₹1,783.70 at 11:04 IST on 6 Nov 2026.
- Volume so far was 10.49× its 20-session average.
- Q2 FY27 net profit: ₹98 crore, +17.26% on a year earlier.
- Nifty Pharma was +0.37%.
Figures as of: 11:04 IST, Friday 6 November 2026
Sai Life Sciences Ltd. (SAILIFE) share price jumped 11.87% to ₹1,783.70 at 11:04 IST on Friday 6 November 2026. The trading volume reached 10.49× the 20-session average. The company filed its Q2 FY27 results on Thursday 5 November 2026, and the stock traded higher on Friday.
Sai Life Sciences share price today
| Price (11:04 IST) | ₹1,783.70 |
| Change from the previous close (₹1,594.50) | +₹189.20 (+11.87%) |
| Day’s range | ₹1,614.90 – ₹1,790.00 |
| Volume so far | 50.5 lakh shares |
| 20-session average daily volume | 4.8 lakh shares (volume so far is 10.49× that) |
| Closing prices of the previous 4 sessions | ₹1,542.30 – ₹1,594.50 |
| 52-week range (adjusted prices) | ₹783.85 – ₹1,697.00 |
| Market value at this price | ₹37,899 crore |
The share price traded between ₹1,614.90 and ₹1,790.00 during the session. Trading volume reached 50.5 lakh shares, which is 10.49× the 20-session average daily volume of 4.8 lakh shares. The current price of ₹1,783.70 is above the 52-week high of ₹1,697.00.
What has been announced
| When (IST) | Filing |
|---|---|
| Fri 6 Nov, 12:17 am | Announcement under Regulation 30 (LODR)-Investor Presentation |
| Fri 6 Nov, 12:13 am | Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Thu 5 Nov, 11:09 pm | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Thu 5 Nov, 11:05 pm | Announcement under Regulation 30 (LODR)-Change in Management |
| Thu 5 Nov, 10:54 pm | Unaudited Financial Results For The Second Quarter And Half Year Ended 30Th September 2026 |
| Thu 5 Nov, 10:48 pm | Board Meeting Outcome for Outcome Of The Board Meeting Held On 05Th November 2026. |
Q2 FY27 results at a glance
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Q1 FY27 | Change |
|---|---|---|---|---|---|
| Revenue from operations | 659 | 537 | +22.53% | 554 | +18.82% |
| Profit before tax | 131 | 112 | +17.16% | 98 | +33.99% |
| Net profit | 98 | 84 | +17.26% | 73 | +34.16% |
| Net profit as a share of revenue | 14.93% | 15.60% | – | 13.22% | – |
For Q2 FY27, revenue from operations was ₹659 crore, which is +22.53% on a year earlier. Profit before tax reached ₹131 crore, representing a +17.16% change on a year earlier. Net profit for the quarter was ₹98 crore, a +17.26% change on a year earlier.
How Sai Life Sciences compares with its sector
| Change today | |
|---|---|
| Sai Life Sciences | +11.87% |
| Nifty Pharma | +0.37% |
| Nifty 50 | +0.22% |
| Glenmark Pharmaceuticals | +4.19% |
| Wockhardt | −3.83% |
| Ipca Laboratories | −1.18% |
| Torrent Pharmaceuticals | +1.11% |
The Nifty Pharma index rose 0.37% while the Nifty 50 gained 0.22%. Among peers, Glenmark Pharmaceuticals rose 4.19% and Torrent Pharmaceuticals gained 1.11%. Wockhardt was −3.83% and Ipca Laboratories was −1.18%.
Sai Life Sciences share price: FAQs
What is the Sai Life Sciences share price today?
₹1,783.70 at 11:04 IST on Friday 6 November 2026, up ₹189.20 or 11.87% from the previous close of ₹1,594.50.
What were Sai Life Sciences’s Q2 FY27 results?
Consolidated revenue from operations of ₹659 crore (+22.53% year on year) and net profit of ₹98 crore (+17.26%), for the quarter ended 30 September 2026.
When did Sai Life Sciences announce the results?
The board meeting outcome was filed on Thu 5 Nov, 10:54 pm IST.
How is the Pharma sector doing today?
Nifty Pharma was +0.37% at 11:04 IST on Friday 6 November 2026, against +11.87% for Sai Life Sciences.
This article is for information only and is not investment advice. Prices are from the National Stock Exchange, filings from BSE announcements and results from the company’s reported figures. Calculations are by ThePip. Prices and figures move through the session; the time above says when these were read. Investments in securities are subject to market risks.